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Expression of major myclin glycoprotcin PO by PO cDNA lransfection into C6 gliomn ccl& promoted homophilic ell adhesion of the cells. After 
the dissociated cells wcrc incubated for various limes, the number of particles at each time point was measured. The total number of particles 
decreased to24% in 60 min for transformant (C6PO) cells, in conlrast lo only 68% for control (CWO’) cells. To cdirm the homophilic mechanism 
of adhesion, mixed-cell aggregation experiments were performed. Among the four synthclic peptides corresponding to a part of the PO scqucncc 
used, only peplide 3 (residues 90-96), which contained a carbohydrate attaching site, caused considerable inhibition of cell aggrcpiion (approxi- 
matcly 50%). In addition, the glycopeptide (r sidues 91-95) obtained from bovine PO markedly inhibited cell aggregation (by approximately 85%). 
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1. INTRODUCTION 
PO protein, a major myclin glycoprotein in mammal- 
ian peripheral nervous system (PNS), has an apparent 
molecular weight of 28,000 Da and is a member of the 
immunoglobulin superfamily [l-5]. Several molecules 
of the immunoglobulin superfamily, including Ll, N- 
CAM, myelin-associated glycoprotein (MAG) and PO, 
play important roles in the development and regenera- 
tion of the nervous system. Ll and N-CAM are cx- 
pressed by non-myelinating Schwann cells before the 
onset of myelination, whereas MAG and PO are ex- 
pressed only by myelinating cells [6]. PO appears at the 
initial stage of myelination and contributes to the for- 
mation and maintenance of myelin compaction as an 
adhesion molecule. Recently direct evidence of homo- 
philic adhesion of PO protein has been reported on the 
basis of recombinant PO expression studies [7-91. We 
have also constructed a PO expression vector under the 
control of theb-actin promoter, transfected this plasmid 
into C6 cells, and reported neurite outgrowlh-promot- 
ing activity of PO protein [lo]. In this study, we prepared 
short synthetic peptides from different regions within PO 
and the glycopeptide of PO protein, and carried out 
competition analysis of the reaggregation assay of PO, 
in order to determine functional domains in the PO-PO 
binding mechanism. 
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2. MATERIALS AND METHODS 
2. I. Plusmid construcrion 
The EcoRI site of expression vector pBact-STneoB [ 1 I] was mcthyl- 
ated with EcoRl methylasc. This plasmid was ciwvcd with Srrll. and 
blunt ended by Klenow enzyme. After joining an EcoRl linker to this 
site. the /&RI fragment of the p5N63s plasmid. containing the full- 
length rat PO cDNA [3], was isolated and cloned into the expression 
vector, pl3actSTneoB (which possesses a strong chick @-actin pro- 
molcr to promote inserted genes, and n neomycin-resistant gene driven 
by the SV40 promoter). The resultant plasmid is pBACTP0. The 
vector in which rat PO cDNA was inserted in the opposiu Jirccdon 
is referred to as pBACTP0’. 
2.2. DNA rmsfecrion 
C6 cells were grown in Dulbecco’s modified Eagle’s medium with 
10% fetal calf serum. For each dish, IOys ofpBACTP0 or pBACWO 
was co-precipitated with calciun: ,rQcsphatc according to standard 
pro-zedurcs [12]. After 3 h of incubation, the cells were glycerol- 
shocked (15% glycerol in HEPES) for l-2 min at room tcmpralurc. 
Stable transformants were selected in medium containing 6OOgyg/ml 
G418 (G&co). After limiting dilution of Gilt-resistant clones. cells 
were furtkcr screened for PO expression by immunostaining with anti- 
PO polyclonal antibody. Stable clone C6PO and C6PO’ arc C6 cell 
transformants with pBACTP0 and pBACTFO’, rcspcctivcly. 
2.3. Producrion of antibodies 
Purified bovine PO protein [4] was mixed with Frcund’s complctc 
adjuvant (Difco) in PBS and injecled into 3 rdbbils at a dose of >300 
,ug of protein/injection. Rabbits were boosted with puriBed protein 
mixed with incomplcu adjuvant in PBS a! 3 and 6 weeks. and bled at 
8 weeks. 
C6 cells were plated on dnss covcrslips coaled with poly-l-lysinc. 
Cells were pm-fixed with 4% parafo’ormaldehydc and then post-lixed 
with 5% acetic acid in ethanol. The cell prepamtion was incubated 
with anti-W polyclonal antibody (l:200). After PBS washing, the 
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samples wet-c treated with secondary antibody (fluoresrGn isothiocya- 
natc-labelled anti-rabbit I&i). These samples were examined with a 
Nikon fluorescence microscope. 
Membrane fractions were obtained according to the method de- 
scribed by Miyawaki et al, [I I], The membrane fractions were boiled 
in SDS sample buffer (2% SDS, 25 mM Tris-HCI (pH 6.8), 5% mer- 
captethanol, 10% glycerol) for 5 min. Proteins wm separated with 
12,546 SDS-PAGE and transfectcd to an Immobilon lilter (Millipore). 
The blots were processed by sequential incubation with blocking 
buffer (1% skimmed milk in PBS), anti-PO polyclonal antibody (I:50 
dilution), and alkaline phosphatase-conjugated nti-rabbit IgG. Final 
staining was carried out in 0.1 M Tris-HCI (pH 9.5). containing 330 
pg/ml Nitro blue tetrazonium, l65~~ml S-bromo-4chloro-3-indonyl 
phosphate, 10 mM MgCll and 0.15 M NaCI. 
The peptides (residues 43-50, 83-90,90-96 and 100-107) of the rat 
PO protein were synthesized with an ABI Model 430A peptide synthe- 
sizer by the Fmoc. method (sequences arc presented inTable I). Puri- 
Rcation of the synthesized fragments was performed by HPLC (Jasco) 
with ODS-column (5y, 46 mm x 25 cm, Beckman) and the purity was 
determined with an ABI 473A protein sequencer [13]. PO glycopeptide 
was purified from bovine PO by Sephadcx G-25 and G-S columns. [14]. 
Cells in monolayer culture were incubated with 2 mM ED-I-A in PBS 
for 15 min at room temperature and then dispersed by gentle pepet- 
ting. The cells were suspended incomplete medium at I x IOb cells/ml 
and then transferred to polystyrene tubes, The cell suspension was 
incubated at 37O C, and aliquots were taken at 15.min intervals after 
mixing by several gentle inversions, The number of cell aggregates 
(particles) was counted in a hemocytometcr. Aggregation was rcpre- 
sented by the index N,/No, where N, and N, are the total number of 
particles at incubation times t and 0, respectively. For competition 
assay, one or the four synthetic peptidcs or PO glycopeptide suspended 
at either 50, 100. 200 or 500 @ml was added in advance of making 
the cell suspension, To test homophilic binding of cells, control C6 
cells (C6PO’) and PO-transfected C6 cells (CGPO) were labelled by 
incubation with 15 pdrnl DiI and DiO, respectively (Molecular 
Probes). for 2 h [l5]. Cells were dispersed and suspended incomplete 
medium as described above and then mixed at a 1: 1 ratio in which total 
cell number was 5 x IO~/ml. After 45 min of incubation at 37” C, 
aliquols were removed from polystyrene tubes, spotted on glass co- 
verslips. and then tixcd in 4% paraformaldehyde in PBS for IO min. 
3. RESULTS 
3.1. Expression of rat PO in gliotna C6 cells 
A rat PO expression vector (pBACTP0) was con- 
structed by cloning the full-length sDNA of rat PO into 
a vector (pDact-STneoB). Rat glioma C6 cells were cho- 
sen at he recipient cells because they do not produce PO 
activity and also grow independently from other adhe- 
sive molecules in subconfluent culture. The expression 
of PO on the membrane surface of stable clones was 
confirmed immunocytochemically using anti-PO poly- 
clonal antibody diluted 1:200, and FITC-conjugated 
anti-rabbit IgG diluted 1:200 as the second antibody, A 
distinct positive band, with an apparent molecular 
weight of 30 kDa was found in the membrane fraction 
of PO transformants by Western blot analysis, using 
-I 
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Fig. I. Short-term aggregation ofCBPO’ and CBPO cells. Values are the 
mean ” S.E.M. for three indepcndcnt enpcrinicnts. N, and No arc the 
total number of particles at incubation times tand 0, respectively. Kate 
of aggregation is represented by the index N,/N,. The total number of 
particles dccreascd 24% in 60 min for CBPO cells. in contrast o only 
68% fci* t--GPO cells. 
anti-PO polyclonal antibody, as reported previously 
ClOl. 
3.2. PO exprcssiorz correlates with cell udfmion 
Whether or not the expression of PO in C6 cells would 
promote cell-cell adhesion in these cells was tested in 
this study. In the first series of experiments, ingle cell 
suspensions were prepared by pipetting the cells in the 
presence of EDTA. Dissociated cells were resuspended 
in complete medium and incubated for various times, 
and the number of particles at each time point was 
measured. A decrease in the number of particles indi- 
cates increased aggregate formation. A significant dif- 
ference was observed in the aggregation kinetics be- 
tween CQPO and CGPO’ cells (Fig. 1). The total number 
of particles decreased to 24% in 60 min for transformant 
(C6PO) cells, in contrast to only 68% for control (CGPO’) 
cells (Fig, 2a,b). The results presented here demonstrate 
a significant correlation of PO expression with cell ag- 
gregation, 
3.3, PO nwdiutes izomphilic cell adhesion 
Cell binding activities, in a homophilic manner, have 
been demonstrated by transfection experiments with 
some adhesion molecules in the immunoglobulin super- 
family, including PO. However. the possibility remains 
that C6 cells express other molecules interacting with PO 
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Fig. 2. Cell aggregation of C6pO cells expressing PO in a homophilic manner. TWO cW labelled with DiI and C6M) cells lab&d with DiO were 
mixed and incubated for 45 min in complete medium. (a) Lower power photograph ofCBP0 aggregated cells. (b) Lower power photograph ofC6PO 
non-aggrcgalcd ells. (c) Fluorescence photograph using a B-2A filter cassette (Nikon). Fluorrscencc of both Dil- and DiO~poahive c lls is shown. 
(d) Fluorescence photograph using a G-2A liltcr cassette (Nikon). Only DiMakllcd cells were detested, 
heterophilically fo cause cell aggregation. To test this 
hypothesis, mixed-cell aggregation experiments with 
DiI-labclled C6PO’ cells and DiO-labellcd C6PO cells 
were performed. These cells were mixed at a I:1 ratio 
and then allowed to aggregate. C6PO cells expressing PO 
adhered predominantly to each other to form aggre- 
gates, with the exception of attachment to a few C6PO’ 
cells at he periphery [Fig. 2c,d). 
3.4. Time-course ofcornpetition of cell-cell adhesion by 
PO peptides 
To define the cell binding site of PO, we have prepared 
four synthetic peptides comprising 7 or 8 amino acids. 
Peptides 1, 2, 3 and 4 correspond to rat PO amino se- 
quence between Gly-43 and Ile-50, He-83 and Tyr-90, 
Tyr-90 and Phe-96 and Val-100 and Val-107, respec- 
tively (Table I). If the cell binding site of PO resides 
within these sequences, these peptides would be ex- 
pected to compete for PO binding. A competition assay 
was used to examine the effect of the four synthetic 
peptides on PO-PO binding. Only peptide 3 was dis- 
tinctly capable of competing for cell binding; the other 
peptides had no effect on PO-expressed cell adhesion, 
except peptide 1 which had a slight effect. We then 
prepared the glycopepridc of PO protein since peptide 3 
includes a carbohydrate domain (Asn-93) of PO. This 
glycopeptide of PO protein markedly inhibited cell adhc- 
sion of CGPO cells (Fig. 3). 
If any of the synthetic peptides or the glycopeptide 
can recognize the homophilic binding site of PO, the 
binding of these peptides to the cell surface PO molecules 
should interfere with cell-cell adhesion. To test this 
property, aggregation-stage c lls were re-associated in
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Fig. 3. Effect of synthetic peptides and purified PO glycopeptide on 
PO-PO binding. Four synthetic peptides or PO glycopeptide were sus- 
pended at 500 pg/rnl in advance of making the cell suspension, Of the 
‘four synthetic peptidcs, only pcptidc 3 (residues 90-96), which con- 
tained a carbohydrate attaching site, showed considerable inhibition 
(approximately 50%) of the cell aggregation. The glycopcptidc mark- 
crlly inhibited (by approximately 85%) the cell aggregation, In addi- 
tion, peptide I (residues 43-50) had a sliyht inhibitory effect. 
the presence of different concentrations of peptide 1, 2, 
3 or glycopeptide. The effect of peptide 1 and 3 and the 
glycopeptide on cell re-association were dose depend- 
ent, and cell aggregation was inhibited by approxi- 
mately 20% 50 and 85% respectively, when these pep- 
tides were included in the assay medium, at SO0 pg/ml. 
On the other hand, peptide 2 had no appreciable ffect 
even at 500 ygml (Fig. 4). 
4. DISCUSSION 
The primary structures of rat [3], shark [16], chicken 
[ 171 and human [ 181 PO proteins were deduced from the 
nucleotide sequences of their dDNAs, and the bovine 
PO sequence was determined irectly by protein chemi- 
cal -methods [43. The PO of 219 residues in mammalian 
peripheral myelin has a single transmembrane s gment 
(125-150) with an amino-terminal domain containing 
an Asn (93)-N-linked carbohydrate unit [4]. Several 
post-translational modifications of PO are known, such 
as glycosylation, acylation [19], phosphorylation [20] 
and sulfation. Because it is one of the simplest molecules 
in the immunoglobulin cell adhesion molecule super- 
family [S], PO presents an attractive model for defining 
the molecular details of adhesive interection. 
sion molecules of the immunoglobulin superfamily, 
such as N-CAM [21, 221, F3/Fll [23], Fasciclin III [24], 
SC1 [25], and Ll [2G], have demonstrated that these 
molecules adhere in a homophilic manner. To address 
the function of PO, several transfection experiments 
have been reported. Filbin et al. showed that Chinese 
hamster ovary (CHO) cells expressing PO, by transfec- 
tion of PO cDNA, showed at least twice the log value 
of magnitude for adhesion than control transfected cells 
[8, 91. They also demonstrated that the adhesion was 
most likely to have been a result of PO homophilic inter- 
action, and not PO interaction with some ubiquitous 
component in the membrane of opposing cells. D’Urso 
et al. [7] expressed PO cDNa in HeLa cells under the 
Table I 
Sequence of synthetic pcptidcs and the glycopeptide of PO and effect 
on cell-ccl1 adhesion 
Pcptide 
None 0 
: (43)GGRDAIS1(50) 8 1VIMNLDY 9 20.3 7.6 
3 (90)YSDNKGTF(96) 50.2 
4 (100)VKNPPDlV(107) 5.1 
CHG 
s (9 I )SDNGT(95)” 35.1 
Transfection experiments of several neural cell adhe- “Glycopeptide 
n Pep.-1 
-I 
q Pap.-2 
60 Ed pep..3 
q G.P. 
50 100 200 500 
Concentration @g/ml) 
Fig. 4. Dose-dependent effcxt of synthetic peptides and PO glycopep- 
tide. Aggregation cells were re-associatcxl in the presence of different 
concentrations ofpeptidc I, 2,3 or glycopeptide. Dose dependency of
cell adhesion inhibition to PO peptides and glycopeptide is demon- 
strated, 
Sequence % inhibition 
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control of the SS40 promoter, and traced the biosynthe- 
sis of PO by analyzing the dynamics of PO insertion into 
membranes. They further provided evidence that the 
extracellular domain of PO insertion into membranes. 
They further provided evidence that the extracellular 
domain of PO functioned homotypically to cause adja- 
cent membrane surfaces of the PO-expressing HeLa cells 
to adhere. PO was also distributed along the cell-cell 
borders in transformants, with the formation of desmo- 
some-like structures between adhering cells occurring. 
.4 recesr report of Filbin and Tennekoon demonstrated 
the importance of oligosaccharide moieties of PO in its 
function as a homophilic adhesion molecule [X’]. Ex- 
pression of the complex form of PO ,glycoprotein in 
transfected CHO cells greatly increased the adhesive- 
ness of those cells, whereas expression of the high-man- 
nose form of PO glycoprotein in the carbohydrate-syn- 
thesizing, enzyme-deficient mutant cells did not. The 
importance of the structure of the oligosaccharide chain 
was emphasized in their report. Schneider-Schaulies t 
al. [29] demonstrated that the extracellular domain frag- 
ment of PO was able to inhibit the adhesion of PO- 
expressing U-1 cells to plates coated with the same 
extracellular domain. This extracellular PO fragment 
lacked carbohydrate, because the soluble peptide was 
obtained using a bacterial expression system. PO was 
able to mediate adhesion to unglycosilated immuno- 
globulin-like domains with other interacting PO mole- 
cules. They presented two possibilities for this phenom- 
enon; (i) the carbohydrate residue of PO may play no 
role in adhesion, or (ii) the carbohydrate residues of one 
PO molecule could interact with regions other than the 
carbohydrates of opposing PO partner molecules. The 
existence of important domains other than the oligosac- 
charide chain, in the extracellular region of PO protein, 
for cell adhesion, was suggested from their report. How- 
ever, in the past, there has been no detailed analysis of 
the functional domain of PO in the extracellular region 
by the competition experiment using synthetic peptides. 
As a first step in this study, we confirmed the ability 
of PO as an homophilic adhesion molecule using PO- 
expressing C6 cells prepared previously [lo]. To deter- 
mine the minimum sequence required for the PO binding 
activity, four different synthetic peptides (peptide I-4)) 
were prepared and used in our studies. All peptides were 
from the amino-terminal domain and only peptide 3 
included the glycosylation site of Asn-93. We have pre- 
sented here evidence, that peptide 3 considerably inhib- 
ited cell aggregation of transformants and peptide 1 
showed slight inhibition by competition assay. Further, 
the glycopeptide fraction purifed from PO had a much 
stronger ability to inhibit PO-PO cell aggregation (Fig. 
3). The effect of these peptides were compared on the 
same weight basis in this experiment. When we com- 
pared the ability by molar basis, inhibition of the 
glycopeptide was much stronger, because the molecular 
weight of glycopeptide is about four times as large as 
those of other peptides. These results suggest hat the 
oligosaccharide chain of PO is the most important for 
the homophilic adhesion of PO protein. In addition, the 
neighboring peptide of the oligosaccharide attaching 
site is also important in PO-PO cell adhesion. Also, there 
remains the possibility that other domains, such as pep- 
tide 1, may assist cell-cell binding involving PO. 
The carbohydrate chain of PO reacted with HNK-1 
/L2 antibody, and was separated into at least five 
subfractions by ion-exchange chromatography. The 
common carbohydrate structure of the glycopeptide 
is Gall-4GlcNAcl-ZManl-3 (Manl_3Manld)Manl- 
4GlcNAcl-4(Fuc I -G)GlcNAc-Asn. The micro-hctero- 
geneity appeared to be due to extra sialic acid, sulfate 
and glucuronic acid contents [28]. In further studies, we 
will be comparing the inhibition of cell adhesion by the 
addition of oligosaccharide subfractions or other pep- 
tides of the PO extracellular region. The active domain 
in the carbohydrate chain will be also analyzed in the 
near future. On the other hand, we recently dcmon- 
strated the neurite outgrowth-promoting activity of PO 
protein using PO-expressing Cb cells and co-cultured 
dorsal root ganglion (DRG) neurons [7]. Because DRG 
neurons do not express PO, it is suggested that the ex- 
tracellular domain of PO can bind with a receptor on 
neurons helerophilically. Kadmon et al. [30] proposed 
a cis-binding interaction between other molecules of the 
immunoglobulin superfamily (N-CAM and Ll) naming 
it “assisted homophilic’ interaction”. Miura et. al. [263 
suspected that the Ll-N-CAM type of adhesion plays 
important roles in the regulation of binding in cell inter- 
action. It is tempting to speculate that PO is not only 
involved in homophilic adhesion but also mediates a 
heterophilic trans-binding mechanism. 
In conclusion, we have demonstrated that the interac- 
tion between one PO-oligosacchalide chain and another 
PO-oligosaccharide chain coupling with the neighboring 
peptides, is most important in its functioning as a homo- 
philic adhesion molecule, and that a second molecule, 
such as peptide 1, could be involved in the stabilization 
of the PO-PO interaction. 
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